KRM Ayurveda came to market through an SME IPO that opened on 21 January 2026 and closed on 23 January 2026, and the shares listed on 29 January 2026 on NSE SME. The price band was ₹128 to ₹135 per share and one lot was 1000 shares, so the minimum application was ₹1,35,000. The issue size was ₹77.49 crore. The whole issue was fresh shares, so the money raised went to the company.
Skyline Financial Services Pvt.Ltd was the registrar to the issue, and NEXGEN Financial Solutions Pvt. Ltd was the lead manager.
As of 23 January 2026.
| Day |
|---|
| 1 |
| 2 |
| 3 |
Incorporated on 3 September 2019, KRM Ayurveda Ltd. operates a network of hospitals and clinics across multiple cities in India and abroad through telemedicine consultation sales. Manufacture a range of Ayurvedic products, herbal and botanical remedies, medicines, supplements, and probably skin care/wellness-related products.Currently, it operates 6 hospitals and 5 clinics across the country. Services & Products: The hospitals Clinic Teleconsultation Services KRM Ayurveda Products.
Accordingly, as of August 31, 2025, the company has an aggregate of 429 employees operating under various departments.
As described in the offer document.
| Metric | 30-Sep-25 | 31-Mar-25 | 31-Mar-24 | 31-Mar-23 |
|---|
Mr. Puneet Dhawan, Mrs. Tanya Dhawan. Promoter holding 92.16% before the issue and 67.28% after.
Work out the listing gain for this SME IPO
If the retail portion is not fully subscribed, every valid application is allotted in full. If it is oversubscribed, SEBI's rules require that as many applicants as possible receive at least one lot, so the shares are allotted by a computerised lottery across all valid applications, one lot each, until the retail portion is exhausted. Applying for more lots does not improve your chance in a lottery; it only increases what you receive if the issue is under-subscribed.
The basis of allotment document, published by the registrar on the allotment date, states the ratio: for example, one applicant in seven received one lot.
Allotment status is published by the registrar on its website, searchable by PAN, application number or demat account, and also on the exchange's website. Allotted shares are credited to the demat account the day before listing, and blocked money for unsuccessful applications is released the same day. The Rupix app can check allotment status by PAN once the registrar publishes it.
Shares list within three working days of the issue closing. On listing day the exchanges run a special pre-open session from nine o'clock, during which orders are collected and an opening price is discovered from them; trading in the share begins after that, usually around ten. The opening price is the listing price that appears on this page once the issue has listed, and the listing gain or loss is the difference between it and the issue price.
For a mainboard issue, the share then trades in the normal way with the exchange's price band for a new listing. For an SME issue, shares trade in lots rather than one at a time, and the market can be thin, so selling on listing day is not always possible at the opening price. Capital gains on shares sold within a year of allotment are short-term and taxed at the short-term rate.
KRM Ayurveda IPO was a ₹77.49 crore book-built issue, made up entirely of a fresh issue. It was priced at ₹128–₹135 per share with a lot size of 1,000 shares; the minimum retail application was 2,000 shares (₹2,70,000). The IPO was open from January 21 to January 23, 2026 and was subscribed 74.43x. Shares listed on NSE SME on January 29, 2026 at ₹172.10, a 27.5% premium to the issue price of ₹135. Skyline Financial Services Pvt. Ltd.
is the registrar. NEXGEN Financial Solutions Pvt. Ltd. is the book running lead manager.
The price band of KRM Ayurveda IPO is ₹128 to ₹135 per share.
The lot size of KRM Ayurveda IPO is 1000 shares.
The minimum investment for KRM Ayurveda IPO is approximately ₹2,70,000 based on the upper price band.
The allotment date of KRM Ayurveda IPO is Jan 27, 2026.
KRM Ayurveda IPO's final recorded GMP before listing was ₹19 per share (a 14% premium over the ₹135 upper price band). The shares listed at ₹172.1. GMP is unofficial and does not forecast or guarantee the actual listing price.
You can check KRM Ayurveda IPO allotment status on the registrar or stock exchange websites using your PAN or application number after allotment. You can also check the KRM Ayurveda IPO allotment status on Rupix for quick and easy access.
₹128 to ₹135 per share, against a face value of ₹10. Most applicants bid at the cut-off price, the top of the band, so that the application was valid whatever price the issuer finally fixed.
One lot was 1000 shares, and every application had to be a whole number of lots. At the top of the band that made the minimum application ₹1,35,000. After listing, SME shares also trade in lots rather than one share at a time.
₹1,35,000, for one lot of 1000 shares at the top of the price band. The amount was blocked in the applicant's bank account through ASBA or a UPI mandate while the issue was open, and released on the allotment date to applicants who were not allotted shares.
It opened on 21 January 2026 and closed on 23 January 2026.
The basis of allotment was published on 27 January 2026 by Skyline Financial Services Pvt.Ltd, and allotted shares were credited to demat accounts before listing.
The shares listed on 29 January 2026 on NSE SME.
The issue size was ₹77.49 crore. The fresh issue was 57,40,000 shares (aggregating up to ₹77.49 crore).